Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.26M | -4.29M | -22.96M | -10.85M | -9.74M |
| Total Depreciation and Amortization | 665.00K | 631.00K | 563.00K | 584.00K | 559.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.97M | -5.28M | 14.26M | 4.11M | 3.53M |
| Change in Net Operating Assets | -1.64M | 1.30M | 2.59M | 1.66M | -522.00K |
| Cash from Operations | -9.27M | -7.64M | -5.55M | -4.50M | -6.17M |
| Capital Expenditure | -779.00K | -613.00K | -1.48M | -1.05M | -349.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -779.00K | -613.00K | -1.48M | -1.05M | -349.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -152.00K | -143.00K | -358.00K | -120.00K | -114.00K |
| Issuance of Common Stock | 10.00K | 26.02M | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -237.00K | -- | -72.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -185.00K | -1.18M | -2.00K | 0.00 | 0.00 |
| Cash from Financing | -564.00K | 24.70M | -252.00K | -120.00K | -114.00K |
| Foreign Exchange rate Adjustments | -16.00K | -10.00K | -15.00K | -105.00K | -105.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.63M | 16.44M | -7.29M | -5.78M | -6.74M |